FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Orexigen Therapeutics, Inc. [ OREX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 05/01/2007 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 05/01/2007 | C | 1,049,042 | A | (1) | 1,049,042 | I | By Sofinnova Venture Partners VI, L.P.(2) | ||
Common Stock | 05/01/2007 | C | 207,844 | A | (1) | 207,844 | I | By Sofinnova Venture Partners VI GmbH & Co. KG(3) | ||
Common Stock | 05/01/2007 | C | 14,300 | A | (1) | 14,300 | I | By Sofinnova Venture Affiliates VI, L.P.(4) | ||
Common Stock | 05/01/2007 | C | 715,256 | A | (1) | 1,764,298 | I | By Sofinnova Venture Partners VI, L.P.(2) | ||
Common Stock | 05/01/2007 | C | 141,712 | A | (1) | 349,556 | I | By Sofinnova Venture Partners VI GmbH & Co. KG(3) | ||
Common Stock | 05/01/2007 | C | 9,750 | A | (1) | 24,050 | I | By Sofinnova Venture Affiliates VI, L.P.(4) | ||
Common Stock | 05/01/2007 | C | 565,253 | A | (1) | 2,329,551 | I | By Sofinnova Venture Partners VI, L.P.(2) | ||
Common Stock | 05/01/2007 | C | 111,992 | A | (1) | 461,548 | I | By Sofinnova Venture Partners VI GmbH & Co. KG(3) | ||
Common Stock | 05/01/2007 | C | 7,705 | A | (1) | 31,755 | I | By Sofinnova Venture Affiliates VI, L.P.(4) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Series A Preferred Stock | (1) | 05/01/2007 | C | 2,098,085 | (1) | (1) | Common Stock | 1,049,042(5) | (1) | 0 | I | By Sofinnova Venture Partners VI, L.P.(2) | |||
Series A Preferred Stock | (1) | 05/01/2007 | C | 415,688 | (1) | (1) | Common Stock | 207,844(5) | (1) | 0 | I | By Sofinnova Venture Partners VI GmbH & Co. KG(3) | |||
Series A Preferred Stock | (1) | 05/01/2007 | C | 28,600 | (1) | (1) | Common Stock | 14,300(5) | (1) | 0 | I | By Sofinnova Venture Affiliates VI, L.P.(4) | |||
Series B Preferred Stock | (1) | 05/01/2007 | C | 1,430,512 | (1) | (1) | Common Stock | 715,256(5) | (1) | 0 | I | By Sofinnova Venture Partners VI, L.P.(2) | |||
Series B Preferred Stock | (1) | 05/01/2007 | C | 283,424 | (1) | (1) | Common Stock | 141,712(5) | (1) | 0 | I | By Sofinnova Venture Partners VI GmbH & Co. KG(3) | |||
Series B Preferred Stock | (1) | 05/01/2007 | C | 19,500 | (1) | (1) | Common Stock | 9,750(5) | (1) | 0 | I | By Sofinnova Venture Affiliates VI, L.P.(4) | |||
Series C Preferred Stock | (1) | 05/01/2007 | C | 1,130,507 | (1) | (1) | Common Stock | 565,253(5) | (1) | 0 | I | By Sofinnova Venture Partners VI, L.P.(2) | |||
Series C Preferred Stock | (1) | 05/01/2007 | C | 223,984 | (1) | (1) | Common Stock | 111,992(5) | (1) | 0 | I | By Sofinnova Venture Partners VI GmbH & Co. KG(3) | |||
Series C Preferred Stock | (1) | 05/01/2007 | C | 15,411 | (1) | (1) | Common Stock | 7,705(5) | (1) | 0 | I | By Sofinnova Venture Affiliates VI, L.P.(4) |
Explanation of Responses: |
1. All of the Issuer's preferred stock automatically converted into common stock on a 2-for-1 basis upon the closing of the Issuer's inital public offering and had no expiration date. |
2. Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the general partner of SV VI, and Michael F. Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI. Such persons and entities disclaim beneficial ownership of shares held by SV VI except to the extent of any pecuniary interest therein. |
3. Shares held by Sofinnova Venture Partners VI GmbH & Co. KG. ("SV VI KG"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the managing limited partner of SV VI KG, and Michael F. Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI KG. Such persons and entities disclaim beneficial ownership of shares held by SV VI KG except to the extent of any pecuniary interest therein. |
4. Shares are held by Sofinnova Venture Affiliates VI, L.P. ("SV VI Affiliates"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the general partner of SV VI Affiliates, and Michael F. Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI Affiliates. Such persons and entities disclaim beneficial ownership of shares held by SV VI Affiliates except to the extent of any pecuniary interest therein. |
5. Reflects 1-for-2 reverse stock split which became effective on May 1, 2007, pursuant to which each share of preferred stock became convertible into 1/2 of a share of common stock. |
Remarks: |
/s/ Patricia Bitar, Attorney-in-fact | 05/03/2007 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |